Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in culture

Thrombosis Research

Volumn 110, Issue 2-3, 2003, Pages 141-147

  Sugawara, Toshiyuki ^a   Yamabe, Hideaki ^a   Osawa, Hiroshi ^a   Kaizuka, Mitsuaki ^a   Shirato, Kenichi ^a   Nakamura, Masayuki ^a   Tamura, Michiko ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Heparin; PTEC; TFPI; Thrombin; Tissue factor

Indexed keywords

ANTIGEN; FIBRIN; HEPARIN; MESSENGER RNA; PROCOAGULANT; PROTEIN; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRIN FORMATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

EID: 0142258728     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00292-5     Document Type: Article

References (38)

1. Yamamoto K., Loskutoff D.J. The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the develop of glomerulonephritis and microthrombosis. Am. J. Pathol. 151:1997;725-734.
2. Enestrom S., Druid H., Rammer L. Fibrin deposition in the kidney in post-ischemic renal damage. Br. J. Exp. Pathol. 69:1988;387-394.
3. Faulk W.P., Gariulo P., McIntyre J.A., Bang N.U. Hemostasis and fibrinolysis in renal transplantation. Semin. Thromb. Hemost. 15:1989;88-98.
4. Wang Y., Pratt J.R., Tam F.W.K., Hartley R.B., Wolff J.A., Olavesen M.G.et al. Upregulation of type 1 plasminogen activator inhibitor mRNA with thrombotic changes in renal grafts. Transplantation. 61:1996;684-689.
5. Wang Y., Pratt J.R., Hartley B., Evans B., Zhang L., Sacks S.H. Expression of type plasminogen activator and type 1 plasminogen activator inhibitor and persistent fibrin deposition in chronic renal allograft failure. Kidney Int. 52:1997;371-377.
6. Wendt Y., Zhang Y.M., Bierhaus A., Kriegsmann J., Deng Y., Waldherr R.et al. Tissue factor expression in an animal model of hydronephrosis. Nephrol. Dial. Transplant. 10:1995;1820-1828.
7. Gordon E.A., Carney D.H. Thrombin receptor occupancy initiates cell proliferation in the presence of phorbol myristate acetate. Biochem. Biophys. Res. Commun. 141:1986;650-656.
8. Zimmerman G.A., McIntry T.M., Prescott S.M. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J. Clin. Invest. 76:1985;2235-2246.
9. Weiss R.H., Maduri M. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J. Biol. Chem. 15:1993;5724-5727.
10. Villamediana L.M., Rondeau E., He C.I., Medcalf R.L., Peraldi M.N., Lacave R.et al. Thrombin regulates components of fibrinolytic system in human meangial cells. Kidney Int. 38:1990;956-961.
11. He C.J., Rondeau E., Medcalf R.L., Lacave R., Schleuning W.D., Sraer J.D. Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J. Cell. Physiol. 146:1991;131-140.
12. Naldini A., Carney D.H., Bocci V., Klimpel K.D., Asuncion M., Soares L.E.et al. Thrombin enhances T cell proliferative responses and cytokine production. Cell. Immunol. 147:1993;367-377.
13. Noda-Heiny H., Fujii S., Sobel B.E. Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Circ. Res. 72:1993;36-43.
14. Grandaliano G., Choudhury G.G., Poptic E., Woodruff K., Barnes J.L., Abboud H.E. Thrombin regulates PDGF expression in bovine glomerular endothelial cell. J. Am. Soc. Nephrol. 9:1998;583-589.
15. Grandaliano G., Monno R., Ranieri E., Gesualdo L., Schena F.P., Martino C.et al. Regenerative and proinflammatory effects of thrombin on human proximal tubular cell. J. Am. Soc. Nephrol. 11:2000;1016-1025.
16. Bajaj M.S., Rana S.V., Wysolmerski R.B., Bajaj S.P. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patient with severe hepatocellular disease. J. Clin. Invest. 79:1987;1874-1878.
17. Iochmann S., Reverdiau-Moalic P., Beaujean S., Rideau E., Lebranchu Y., Bardos P.et al. Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction. Thromb. Res. 94:1999;165-173.
18. Lwaleed B.A., Bass P.S., Chisholm M., Francis J.L. Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury? J. Clin. Pathol. 50:1997;336-340.
19. Bajaj M.S., Bajaj S.P. Tissue factor pathway inhibitor: potential therapeutic applications. Thromb. Haemost. 78:1997;471-477.
20. Werling R.W., Zacharski L.R., Kisiei W., Bajaj S.P., Memoli V.A., Rousseau S.M. Distribution of tissue factor pathway inhibitor in normal and malignant human tissue. Thromb. Haemost. 69:1993;366-369.
21. Bajaj M.S., Kuppuswamy M.N., Saito H., Spitzer S.G., Bajaj S.P. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium in the principal site of its synthesis. Proc. Natl. Acad. Sci. U. S. A. 87:1990;8869-8873.
22. Wojtukiewicz M.Z., Zacharski L.R., Rucinski M., Zimnoch L., Jaromin J., Rozanska-Kudelske M.et al. Expression on tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma. Thromb. Haemost. 82:1999;1659-1662.
23. Bajaj M.S., Kuppuswamy M.N., Manepali A.N., Bajaj S.P. Transcriptional expression of tissue factor pathway inhibitor, thromobomodulin and von Willebrand factor in normal tissues. Thromb. Haemost. 82:1999;1047-1052.
24. Bajaj M.S., Penduli U., Koenig K., Pueblitz S., Idell S. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells. Eur. Respir. J. 15:2000;1069-1078.
25. Yamabe H., Osawa H., Inuma H., Kaizuka M., Tamura N., Tsunoda S.et al. Tissue factor pathway inhibitor production by human mesangial cells in culture. Thromb. Haemost. 76:1996;215-219.
26. Warn-Carmer B.J., Maki S.L., Zievelin A., Rapaport S.I. Partial purification and characterization of the extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor). Thromb. Res. 48:1987;11-22.
27. Novotny W.F. Tissue factor pathway inhibitor. Semin. Thromb. Hemost. 20:1994;101-108.
28. Tipping P.G., Holdworth S.R. The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Am. J. Pathol. 124:1986;10-17.
29. Wiggins R.C., Glatfelter A., Brukman J. Procoagulant activity in glomeruli and urine of rabbits with nephrotoxic nephritis. Lab. Invest. 53:1985;156-164.
30. Tipping P.G., Erlich J.H., Apostolopous J., Hordworth S.R. Expression of tissue factor pathway inhibitor (TFPI) in fibrin dependent crescentric glomerulonephritis in rabbits. J. Am. Soc. Nephrol. 5:1994;796.
31. Wiggins R.C., Njoku N., Sedor J.R. Tissue factor production by cultured rat mesangial cells. Stimulation by TNF- and lipopolysaccaride. Kidney Int. 37:1990;1281-1285.
32. Novotny W.F., Girard T.J., Miletich J.P., Broze G.J. Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 72:1988;2020-2025.
33. Lupu C., Lupu F., Dennehy U., Kakkar V.V., Scully M.F. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler. Vasc. Biol. 15(11):1995;2055-2062.
34. Sandset P.M., Abildgaard U., Larsen M.L. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb. Res. 50:1988;803-813.
35. Kario K., Matsuo T., Yamada T., Matsuo M. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis. Thromb. Haemost. 71:1994;275-279.
36. Norrheim L., Abildgaard U., Larsen M.L., Lindahl A.K. Involvement of extrinsic pathway in the actives of low molecular weight heparins. Thromb. Res. 14:1991;19-27.
37. Abildgaard U. Heparin/low molecular weight heparin and tissue factor pathway inhibitor. Haemostasis. 23:1993;103-106.
38. Harenberg J., Siegele M., Dempfle C.E., Stehle G., Heene D.L. Protamine neutralization of release of tissue factor pathway inhibitor activity by heparins. Thromb. Haemost. 70:1993;942-945.